Literature DB >> 2107545

Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I alpha 3 domain: CD8 and the T-cell receptor recognize the same class I molecule.

J M Connolly1, T H Hansen, A L Ingold, T A Potter.   

Abstract

The CD8 molecule on class I-reactive cytotoxic T lymphocytes (CTLs) is believed to function as a coreceptor along with the alpha beta T-cell receptor. Whereas the alpha beta T-cell receptor recognizes polymorphic residues in the alpha 1/alpha 2 domains of the class I molecule, the CD8 molecule is believed to recognize monomorphic class I residues. Our previous experiments suggested that residue 227 in the alpha 3 domain of major histocompatibility complex class I molecules contributes to the determinant recognized by CD8. By using a panel of site-directed mutants of H-2Dd, this observation has been extended herein. Our findings indicate that for recognition by CD8-dependent CTLs, residue 227 must be either glutamic acid or aspartic acid and cannot be either basic or uncharged. However, the recognition by CD8-independent CTLs is unaffected by any of the substitutions at position 227 of H-2Dd. Similarly, alterations of other charged residues at positions 222, 223, and 229 have an analogous effect to substitution at residue 227, whereas substitutions at residues 192 and 232 do not affect the reactivity of CD8-dependent or CD8-independent CTLs. In addition, mutant H-2Dd molecules that are not recognized by CD8-dependent CTLs are unable to stimulate a primary CTL response, yet they can stimulate a secondary CD8-independent H-2Dd-specific CTL response. These findings suggest that CD8 recognition is obligatory for the priming of class I-dependent CTL responses. Since endogenous class I molecules were expressed by all of the transfected cell lines, these findings provide direct genetic evidence that CD8 and the alpha beta T-cell receptor must interact with the same class I molecule.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2107545      PMCID: PMC53641          DOI: 10.1073/pnas.87.6.2137

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Synergism in the activation of human CD8 T cells by cross-linking the T-cell receptor complex with the CD8 differentiation antigen.

Authors:  F Emmrich; U Strittmatter; K Eichmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

Review 2.  The co-receptor function of murine CD4.

Authors:  C A Janeway; J Rojo; K Saizawa; U Dianzani; P Portoles; J Tite; S Haque; B Jones
Journal:  Immunol Rev       Date:  1989-06       Impact factor: 12.988

3.  Domain interactions of H-2 class I antigens alter cytotoxic T-cell recognition sites.

Authors:  H Allen; D Wraith; P Pala; B Askonas; R A Flavell
Journal:  Nature       Date:  1984 May 17-23       Impact factor: 49.962

Review 4.  Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes (CTL): possible implications for the affinity of CTL antigen receptors.

Authors:  H R MacDonald; A L Glasebrook; C Bron; A Kelso; J C Cerottini
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

5.  Exon shuffling: mapping polymorphic determinants on hybrid mouse transplantation antigens.

Authors:  G A Evans; D H Margulies; B Shykind; J G Seidman; K Ozato
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

6.  Hybrid H-2 histocompatibility gene products assign domains recognized by alloreactive T cells.

Authors:  K Ozato; G A Evans; B Shykind; D H Margulies; J G Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

7.  Allospecific and virus-specific cytolytic T lymphocytes are restricted to the N or C1 domain of H-2 antigens expressed on L cells after DNA-mediated gene transfer.

Authors:  C S Reiss; G A Evans; D H Margulies; J G Seidman; S J Burakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

8.  Monoclonal antibodies to mouse major histocompatibility complex antigens.

Authors:  K Ozato; N M Mayer; D H Sachs
Journal:  Transplantation       Date:  1982-09       Impact factor: 4.939

9.  Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera.

Authors:  E Nakayama; H Shiku; E Stockert; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

10.  T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views.

Authors:  J A Ledbetter; R V Rouse; H S Micklem; L A Herzenberg
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

View more
  37 in total

1.  Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement.

Authors:  Samantha E Kerry; Jennifer Buslepp; Lorraine A Cramer; Robert Maile; Lucinda L Hensley; Alma I Nielsen; Paula Kavathas; Barbara J Vilen; Edward J Collins; Jeffrey A Frelinger
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

2.  Heterozygosity at individual amino acid sites: extremely high levels for HLA-A and -B genes.

Authors:  P W Hedrick; T S Whittam; P Parham
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

3.  Structure of CD8 alpha and beta chains of the orangutan: novel patterns of mRNA splicing encoding hingeless polypeptides.

Authors:  D A Lawlor; P Parham
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

4.  Staphylococcal enterotoxin A and toxic shock syndrome toxin compete with CD4 for human major histocompatibility complex class II binding.

Authors:  S Bavari; R G Ulrich
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

5.  Cross-dressed CD8α+/CD103+ dendritic cells prime CD8+ T cells following vaccination.

Authors:  Lijin Li; Sojung Kim; John M Herndon; Peter Goedegebuure; Brian A Belt; Ansuman T Satpathy; Timothy P Fleming; Ted H Hansen; Kenneth M Murphy; William E Gillanders
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

6.  Novel nonclassical MHC class Ib genes associated with CD8 T cell development and thymic tumors.

Authors:  Ana Goyos; Yuko Ohta; Sergey Guselnikov; Jacques Robert
Journal:  Mol Immunol       Date:  2009-02-23       Impact factor: 4.407

7.  Formation of supramolecular activation clusters on fresh ex vivo CD8+ T cells after engagement of the T cell antigen receptor and CD8 by antigen-presenting cells.

Authors:  T A Potter; K Grebe; B Freiberg; A Kupfer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

8.  Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position.

Authors:  Rui Wang; Kannan Natarajan; David H Margulies
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

9.  A heterodimer of HEB and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines.

Authors:  S Sawada; D R Littman
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

10.  Major histocompatibility complex class I genes of the coelacanth Latimeria chalumnae.

Authors:  U A Betz; W E Mayer; J Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.